If I had to look at this objectively and un-biased, the
If I had to look at this objectively and un-biased, the other investors in this group must have considered the baggage from Tony and Pestell. They can't be super stupid to think all the non-5% investors would look past these 2 individuals. I am all for some talented board members and a replacement for Nader IF they actually have something to offer. We don't know yet but the 5% are already starting off in the ditch with Tony and Pestell.
The big criticism of Nader is a lack of industry experience and a rough on the edges communication style. If a candidate was proposed with a real plan to get to the next level, great. I don't see much of anything to suggest Rosenbaum is any better suited than Nader. Patterson may be an asset, however he likely would not have any interest unless the whole board and management team was replaced.
My guess is that this 5% have a plan that has been in the making for some time. The 13d filing was a "no turning back" moment for this group. They made the call that enough was enough in there minds. I do think the compensation committee vote to enrich the BOD and mgmt. team was part of a defense against this group years ago, the lawsuit was a response to it knowing that unless they removed the shares given to the BOD and mgmt., they would not be able to get to 5% as easily. This 13d being filed so soon after the lawsuit settlement is not a coincidence.
What is the 5% plan? I remember Nader mentioning a low-ball offer years ago that he had to fight against. It could be Tony was working on a deal which would explain the silence at that time. I feel the plan is that they want to take control and sell the company ASAP. I don't think they have any idea how to run the company or what they would do differently etc..
don't get me wrong, If Nader really has hit a wall and just can't get this across the finish line for whatever reason, then partnering/selling might be the best option. It could be the gap between what Nader thinks cytodyn is worth and what is being offered is maybe that Nader has a crazy high number in his head that really scared away all opportunities. Could be the opportunities found this 5% group to be there best option to get ownership of the drug. This could really blow up in the 5% face also. The BP that might be watching this could really be using this to smother cytodyn.
As much as the next few months will be a rollercoaster of trial results and possible purchase orders, there will also be a big effort to derail and distract. As if getting a drug approved was not enough.
10
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
UPM-Kymmene Shakes Things Up Here's the meat and potatoes: UPM-Kymmene Corporation is going through a big change. They've decided to cut a part of themselves off and send it out into the world. This partial demerger has been registered, and now WISA Group Plc is stepping out from UPM's shadow. Where to? They're headed for the big league, getting listed on Nasdaq Helsinki....
Continue Reading
Orthocell's October Surprise with Remplir™ Sales Well, isn't this a breath of fresh air? Orthocell Limited just reported a staggering rise in its U.S. Remplir™ sales for October 2026. We're talking 92 units shifting off the shelves, pulling in a tidy AU$279,000. That's an 84% leap compared to the average monthly sales of 50 units in Q1 FY27. It seems the company's...
Continue Reading
Unveiling a New Era for Cross-Border Payments Thunes is shaking things up, unleashing a fresh wave of possibilities for moving money into China's mainland. In a strategic twist, Thunes has teamed up with UnionPay International, aiming to transform the cross-border payment experience. With a potent combo of bank-grade security and hefty daily transaction limits, this...
Continue Reading
Introducing the AI Revolution in Film Here we are, folks, standing at the intersection of film and artificial intelligence. China's entertainment behemoth, iQIYI, has just launched what they're touting as the country's first AI Film Studio over in Shanghai. Kicking things off, they've got "Cop in Trouble" queued up, a film that’s promising to leverage the unbridled...
Continue Reading
Gildan's Legal Storm: Fraud Allegations When news hits about a big player like Gildan Activewear (NYSE: GIL) facing a class-action lawsuit, it's like a thunderstorm for investors who traded their stocks between February 19, 2025, and June 15, 2026. This lawsuit alleges what we some might call classic financial engineering—channel stuffing to be precise—that’s got...
Continue Reading
Dive into the World of Flooring Acclimation You ever hear about flooring acclimation? Sounds as riveting as watching paint dry, right? But Austin J. Messina from Salem, New Hampshire, is here to tell us it's the secret to flooring that doesn't buckle under pressure—literally. Messina's insights, splashed across the pages of HelloNation, delve deep into the nitty-gritty...
Continue Reading
A Celebration of Culture and Integration Here's an event that flips the script on the typical festival circuit: the 2026 Yangtze River Culture Festival. It's as much about heritage as it is about economics, dovetailing culture with tourism in a way that makes wallets a little fatter and souls a little richer. Kicking off in Yonglian Village, Zhangjiagang, this festival...
Continue Reading
When the Rubber Hits the Road: Coverage Gaps Ever been in a fender bender and found out the other driver’s insurance barely covers a dent, let alone a serious crash? Believe me, it's no picnic. Chuck Clark from HelloNation digs into this with a deep dive on underinsured motorist coverage, or UIM for short. It's an eye-opener—especially if you're assuming your auto...
Continue Reading
Redefining Commerce in the Digital Age Alright, folks, let's chew the fat over something that's flipping the script on digital commerce. Coda, the Southeast Asian powerhouse in digital content monetization, is stirring things up with TikTok Gaming. Since June, it's been cooking up one billion views worth of creative potential from users, tightening the grip on digital...
Continue Reading
What's the Deal With Those Ancient Quotes? There's nothing like a quote from the Warring States Period to set the stage for good ol' fashioned governance chatter. Lu Buwei's words about rulers and compass points is historic, sure, but it speaks to the core need for standards in today's China. This isn't just some fortune cookie wisdom; it's a clarion call for order and...
Continue Reading
Top 5 Most Recently Viewed Articles
Data Ramp Unveils Groundbreaking Technology: 1lx Data Ramp, a pioneer in zero-copy data integration, has made headlines with the introduction of 1lx, an innovative technology designed specifically for organizations looking to revolutionize how they handle and enrich customer data. This state-of-the-art solution addresses common data management challenges, allowing...
Continue Reading
Recent Findings on Zigakibart for IgA Nephropathy Recent data from an extended study on zigakibart reveal significant insights into its efficacy and safety as a treatment for IgA nephropathy. Presentations at a notable medical congress highlighted how this investigational monoclonal antibody could transform treatment approaches for this kidney disorder. Understanding IgA...
Continue Reading
Hotel del Coronado's Stunning Transformation and Restoration The legendary Hotel del Coronado has reached an amazing milestone, celebrating the completion of its monumental restoration project valued at over $550 million. This revitalization initiative focuses on preserving the historical significance of the iconic Victorian building while introducing a new era of luxury...
Continue Reading
Exciting Developments in the Tech World The week brought a wave of fascinating news stories from the tech industry, capturing the attention of enthusiasts and investors alike. With significant events like a dispute involving Disney and Google, notable sales achievements for Apple's latest iPhone, and the implications of a major AWS outage, we delve into these key moments....
Continue Reading
Exciting Drilling Progress at Escacena and Cármenes Projects TSXV: PGZ | OTCQB: PGZFF | FRA: 2EU Pan Global Resources Inc. (TSXV: PGZ) is thrilled to share significant advancements regarding its ongoing drill programs at two of its flagship sites, the Escacena Project and the Cármenes Project. These initiatives target high-priority mineralization prospects, including...
Continue Reading